184 related articles for article (PubMed ID: 33007434)
1. Positron Emission Tomography Imaging of Functional Transforming Growth Factor β (TGFβ) Activity and Benefit of TGFβ Inhibition in Irradiated Intracranial Tumors.
Gonzalez-Junca A; Reiners O; Borrero-Garcia LD; Beckford-Vera D; Lazar AA; Chou W; Braunstein S; VanBrocklin H; Franc BL; Barcellos-Hoff MH
Int J Radiat Oncol Biol Phys; 2021 Feb; 109(2):527-539. PubMed ID: 33007434
[TBL] [Abstract][Full Text] [Related]
2. PET with the 89Zr-labeled transforming growth factor-β antibody fresolimumab in tumor models.
Oude Munnink TH; Arjaans ME; Timmer-Bosscha H; Schröder CP; Hesselink JW; Vedelaar SR; Walenkamp AM; Reiss M; Gregory RC; Lub-de Hooge MN; de Vries EG
J Nucl Med; 2011 Dec; 52(12):2001-8. PubMed ID: 22072706
[TBL] [Abstract][Full Text] [Related]
3. TGF-β Antibody Uptake in Recurrent High-Grade Glioma Imaged with 89Zr-Fresolimumab PET.
den Hollander MW; Bensch F; Glaudemans AW; Oude Munnink TH; Enting RH; den Dunnen WF; Heesters MA; Kruyt FA; Lub-de Hooge MN; Cees de Groot J; Pearlberg J; Gietema JA; de Vries EG; Walenkamp AM
J Nucl Med; 2015 Sep; 56(9):1310-4. PubMed ID: 26135113
[TBL] [Abstract][Full Text] [Related]
4. Resistance of glioblastoma-initiating cells to radiation mediated by the tumor microenvironment can be abolished by inhibiting transforming growth factor-β.
Hardee ME; Marciscano AE; Medina-Ramirez CM; Zagzag D; Narayana A; Lonning SM; Barcellos-Hoff MH
Cancer Res; 2012 Aug; 72(16):4119-29. PubMed ID: 22693253
[TBL] [Abstract][Full Text] [Related]
5. Antitransforming growth factor-beta antibody 1D11 ameliorates normal tissue damage caused by high-dose radiation.
Anscher MS; Thrasher B; Rabbani Z; Teicher B; Vujaskovic Z
Int J Radiat Oncol Biol Phys; 2006 Jul; 65(3):876-81. PubMed ID: 16751069
[TBL] [Abstract][Full Text] [Related]
6. TGFβ1 inhibition increases the radiosensitivity of breast cancer cells in vitro and promotes tumor control by radiation in vivo.
Bouquet F; Pal A; Pilones KA; Demaria S; Hann B; Akhurst RJ; Babb JS; Lonning SM; DeWyngaert JK; Formenti SC; Barcellos-Hoff MH
Clin Cancer Res; 2011 Nov; 17(21):6754-65. PubMed ID: 22028490
[TBL] [Abstract][Full Text] [Related]
7. Attenuation of the DNA damage response by transforming growth factor-beta inhibitors enhances radiation sensitivity of non-small-cell lung cancer cells in vitro and in vivo.
Du S; Bouquet S; Lo CH; Pellicciotta I; Bolourchi S; Parry R; Barcellos-Hoff MH
Int J Radiat Oncol Biol Phys; 2015 Jan; 91(1):91-9. PubMed ID: 25835621
[TBL] [Abstract][Full Text] [Related]
8. Tumor localization of an anti-TGF-β antibody and its effects on gliomas.
Hülper P; Schulz-Schaeffer W; Dullin C; Hoffmann P; Harper J; Kurtzberg L; Lonning S; Kugler W; Lakomek M; Erdlenbruch B
Int J Oncol; 2011 Jan; 38(1):51-9. PubMed ID: 21109925
[TBL] [Abstract][Full Text] [Related]
9. TGFβ Blockade Enhances Radiotherapy Abscopal Efficacy Effects in Combination with Anti-PD1 and Anti-CD137 Immunostimulatory Monoclonal Antibodies.
Rodríguez-Ruiz ME; Rodríguez I; Mayorga L; Labiano T; Barbes B; Etxeberria I; Ponz-Sarvise M; Azpilikueta A; Bolaños E; Sanmamed MF; Berraondo P; Calvo FA; Barcelos-Hoff MH; Perez-Gracia JL; Melero I
Mol Cancer Ther; 2019 Mar; 18(3):621-631. PubMed ID: 30683810
[TBL] [Abstract][Full Text] [Related]
10. Esophageal Adenocarcinoma Cells and Xenograft Tumors Exposed to Erb-b2 Receptor Tyrosine Kinase 2 and 3 Inhibitors Activate Transforming Growth Factor Beta Signaling, Which Induces Epithelial to Mesenchymal Transition.
Ebbing EA; Steins A; Fessler E; Stathi P; Lesterhuis WJ; Krishnadath KK; Vermeulen L; Medema JP; Bijlsma MF; van Laarhoven HWM
Gastroenterology; 2017 Jul; 153(1):63-76.e14. PubMed ID: 28286209
[TBL] [Abstract][Full Text] [Related]
11. STI571 (Gleevec) improves tumor growth delay and survival in irradiated mouse models of glioblastoma.
Geng L; Shinohara ET; Kim D; Tan J; Osusky K; Shyr Y; Hallahan DE
Int J Radiat Oncol Biol Phys; 2006 Jan; 64(1):263-71. PubMed ID: 16274936
[TBL] [Abstract][Full Text] [Related]
12. CD4
Kristensen LK; Fröhlich C; Christensen C; Melander MC; Poulsen TT; Galler GR; Lantto J; Horak ID; Kragh M; Nielsen CH; Kjaer A
Theranostics; 2019; 9(26):8221-8238. PubMed ID: 31754392
[TBL] [Abstract][Full Text] [Related]
13. ImmunoPET Imaging of CD146 Expression in Malignant Brain Tumors.
Hernandez R; Sun H; England CG; Valdovinos HF; Barnhart TE; Yang Y; Cai W
Mol Pharm; 2016 Jul; 13(7):2563-70. PubMed ID: 27280694
[TBL] [Abstract][Full Text] [Related]
14. Blockade of TGF-β signaling by the TGFβR-I kinase inhibitor LY2109761 enhances radiation response and prolongs survival in glioblastoma.
Zhang M; Kleber S; Röhrich M; Timke C; Han N; Tuettenberg J; Martin-Villalba A; Debus J; Peschke P; Wirkner U; Lahn M; Huber PE
Cancer Res; 2011 Dec; 71(23):7155-67. PubMed ID: 22006998
[TBL] [Abstract][Full Text] [Related]
15. Blockade of MMP14 activity in murine breast carcinomas: implications for macrophages, vessels, and radiotherapy.
Ager EI; Kozin SV; Kirkpatrick ND; Seano G; Kodack DP; Askoxylakis V; Huang Y; Goel S; Snuderl M; Muzikansky A; Finkelstein DM; Dransfield DT; Devy L; Boucher Y; Fukumura D; Jain RK
J Natl Cancer Inst; 2015 Apr; 107(4):. PubMed ID: 25710962
[TBL] [Abstract][Full Text] [Related]
16. Effective chemoimmunotherapy with anti-TGFβ antibody and cyclophosphamide in a mouse model of breast cancer.
Chen X; Yang Y; Zhou Q; Weiss JM; Howard OZ; McPherson JM; Wakefield LM; Oppenheim JJ
PLoS One; 2014; 9(1):e85398. PubMed ID: 24416401
[TBL] [Abstract][Full Text] [Related]
17. Irradiation-Modulated Murine Brain Microenvironment Enhances GL261-Tumor Growth and Inhibits Anti-PD-L1 Immunotherapy.
Garbow JR; Johanns TM; Ge X; Engelbach JA; Yuan L; Dahiya S; Tsien CI; Gao F; Rich KM; Ackerman JJH
Front Oncol; 2021; 11():693146. PubMed ID: 34249742
[TBL] [Abstract][Full Text] [Related]
18. Impact of 11C-methionine positron emission tomography/computed tomography on radiation therapy planning and prognosis in patients with primary brain tumors.
Schinkelshoek M; Lopci E; Clerici E; Alongi F; Mancosu P; Rodari M; Navarria P; van der Hiel B; Scorsetti M; Chiti A
Tumori; 2014; 100(6):636-44. PubMed ID: 25688497
[TBL] [Abstract][Full Text] [Related]
19. Monitoring Src status after dasatinib treatment in HER2+ breast cancer with
McKnight BN; Viola-Villegas NT
Breast Cancer Res; 2018 Oct; 20(1):130. PubMed ID: 30359299
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]